Monoclonal Antibody definition

Monoclonal Antibody means an antibody derived from a single antibody producing cell, typically produced in mouse ascites fluid or in cell culture, which reacts with a single, unique antigenic site.
Monoclonal Antibody or “mAb” shall mean an antibody produced by a single clone of cells or cell line.”
Monoclonal Antibody means the parvovirus injectable monoclonal antibody known as KIND-030, as described in the patent application [***] filed by KindredBio [***] and its [***]derivatives.

Examples of Monoclonal Antibody in a sentence

  • Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.

  • Low-Density Lipoprotein Cholesterol-Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia: The Reduction of LDL-C With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) Randomized Trial.

  • The Platelet Immunofluorescence Test (PIFT) with a flow cytometric endpoint and the Monoclonal Antibody Immobilisation of Platelet Antigen (MAIPA) assay together with a panel of HPA typed platelets are used to facilitate the detection and identification of antibodies directed against platelet membrane glycoproteins.

  • A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.New England Journal of Medicine 2020;384(10):905-14.

  • The Granulocyte Immunofluorescence Test (GIFT) with a flow cytometric endpoint, the Granulocyte Chemiluminescence Test (GCLT), and the Monoclonal Antibody Immobilisation of Granulocyte Antigen (MAIGA) assay are used together with an HNA typed granulocyte panel to facilitate the detection and identification of antibodies directed against granulocyte membrane glycoproteins.

  • Potential Sources of Inter-Subject Variability in Monoclonal Antibody Pharmacokinetics.

  • DARZALEX® (daratumumab) Approved by U.S. FDA: First Human Anti-CD38 Monoclonal Antibody Available for the Treatment of Multiple Myeloma.” Issued November 16, 2015.

  • VRC 602 (NCT01993706) is titled, “A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults.” VRC 602 was the first study of the VRC01 mAb in HIV-uninfected adults.

  • Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors.

  • For monoclonal antibodies, refer to the guidance on “Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use” (Ref.


More Definitions of Monoclonal Antibody

Monoclonal Antibody means any intact monoclonal antibody and antigen- binding antibody fragments thereof involving single chain fragments, monovalent fragments, and single domain fragments (also called nanobodies). ​ 3. Schedule 1.91 of the Agreement (Late Lead Optimization Activities) is hereby deleted in its entirety and replaced with the attached Schedule 1.91. ​ 4. Schedule 1.182 of the Agreement (Threshold Activity and Selectivity) is hereby deleted in its entirety and replaced with the attached Schedule 1.182. ​ 5. The Agreement is hereby amended to add the Research Plan set forth as Schedule 1.182(c). ​
Monoclonal Antibody means IDEC's 2B8 monoclonal antibody for use in the treatment of non-Xxxxxxxx lymphoma.
Monoclonal Antibody means a monoclonal antibody that specifically and selectively binds Trp-p8, including, without limitation, such monoclonal antibodies that are humanized antibodies.
Monoclonal Antibody means IDEC's 2B8 monoclonal antibody for use in the treatment of non-Hodgkins lymphoma.
Monoclonal Antibody means any monoclonal antibody, fragment, modifications or derivative thereof, which binds to LAG-3 and causes [***].

Related to Monoclonal Antibody

  • Antibody means a molecule comprising or containing one or more immunoglobulin variable domains or any fragments, derivatives, variants or modifications thereof that bind to the same antigen.

  • Opioid antagonist means a drug that binds to opioid

  • Receptor means enclosed spaces, conduits, protected groundwater sources, drinking and non-drinking water wells, surface water bodies, and public water systems which when impacted by chemicals of concern may result in exposure to humans and aquatic life, explosive conditions or other adverse effects on health, safety and the environment as specified in these rules.

  • Antigen means a substance recognized by the body as being foreign; it results in the production of specific antibodies directed against it.

  • Vaccine means a specially prepared antigen which, upon administration to a person, will result in immunity and, specifically for the purposes of this rule, shall mean influenza and pneumococcal vaccines.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Licensed Compound means [***].

  • Corrosion inhibitor means a substance capable of reducing the corrosivity of water toward metal plumbing materials, especially lead and copper, by forming a protective film on the interior surface of those materials.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • Biological product means a virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, protein other than a chemically synthesized polypeptide, or analogous product, or arsphenamine or any derivative of arsphenamine or any other trivalent organic arsenic compound, applicable to the prevention, treatment, or cure of a disease or condition of human beings.

  • Biological agent shall mean any pathogenic (disease producing) micro-organism(s) and/or biologically produced toxin(s) (including genetically modified organisms and chemically synthesized toxins) which cause illness and/or death in humans, animals or plants.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Preceptor means an individual who provides, directs, or verifies training and experience required for an individual to become an authorized user, an authorized medical physicist, an authorized nuclear pharmacist, or a radiation safety officer.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Manufacturing Technology means any and all patents, patent applications, know-how, and all intellectual property rights associated therewith that are owned or controlled by Licensor, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno-associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Therapeutic Product means a health product categorised as a therapeutic product in the First Schedule to the Act;

  • Reagent means any product other than fuel that is stored on-board the vehicle and is provided to the exhaust after-treatment system upon request of the emission control system.

  • Cannabinoid edible means food or potable liquid into which a cannabinoid concentrate, cannabinoid extract or dried marijuana leaves or flowers have been incorporated.

  • Compounds means any or all of the following chemicals, as the context requires:

  • Genetic material means any material of plant, animal, microbial or other origin containing functional units of heredity.

  • HIV means human immunodeficiency virus.

  • Biological Material means any material containing genetic information and capable of reproducing itself or being reproduced in a biological system;

  • Vapor product means any: